Groupe Gorge [GOE] vs Neurones S.A [NRO] Detailed Stock Comparison
Groupe Gorge
Euronext
Loading...
Neurones S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Groupe Gorge wins in 9 metrics, Neurones S.A wins in 6 metrics, with 0 ties. Groupe Gorge appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Groupe Gorge | Neurones S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 37.96 | 19.13 | Neurones S.A |
| Price-to-Book Ratio | N/A | 2.56 | N/A |
| Debt-to-Equity Ratio | 3.21 | 0.10 | Neurones S.A |
| PEG Ratio | -0.05 | 18.09 | Groupe Gorge |
| EV/EBITDA | 47.24 | 6.46 | Neurones S.A |
| Profit Margin (TTM) | 58.30% | 6.10% | Groupe Gorge |
| Operating Margin (TTM) | 7.89% | 7.80% | Groupe Gorge |
| EBITDA Margin (TTM) | 7.89% | 7.80% | Groupe Gorge |
| Return on Equity | 98.04% | 12.05% | Groupe Gorge |
| Return on Assets (TTM) | 13.11% | 7.24% | Groupe Gorge |
| Free Cash Flow (TTM) | N/A | $72.35M | N/A |
| Dividend Yield | N/A | 2.76% | N/A |
| 1-Year Return | 463.93% | -7.46% | Groupe Gorge |
| Price-to-Sales Ratio (TTM) | 6.38 | 1.17 | Neurones S.A |
| Enterprise Value | $1.24B | $693.46M | Groupe Gorge |
| EV/Revenue Ratio | 6.94 | 0.86 | Neurones S.A |
| Revenue per Share (TTM) | $10 | $33 | Neurones S.A |
| Earnings per Share (Diluted) | $2.68 | $2.08 | Groupe Gorge |
| Beta (Stock Volatility) | N/A | 0.53 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Groupe Gorge vs Neurones S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Groupe Gorge | 1.75% | -14.68% | -8.35% | 15.02% | 190.59% | 444.05% |
| Neurones S.A | -1.73% | 0.00% | -6.37% | -15.89% | -19.64% | -9.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Groupe Gorge | 463.93% | 492.33% | 825.09% | 326.23% | 1,281.82% | 1,281.82% |
| Neurones S.A | -7.46% | 21.41% | 67.51% | 140.61% | 375.45% | 375.45% |
News Based Sentiment: Groupe Gorge vs Neurones S.A
Groupe Gorge
News based Sentiment: POSITIVE
The analyst 'Buy' recommendation and +12% price target increase are positive developments for Exail Technologies, suggesting potential for growth. While the 'Negative' technical opinion adds a layer of caution, the overall sentiment is optimistic based on the available information.
Neurones S.A
News based Sentiment: MIXED
Neurones S.A. reported revenue growth but also a decrease in net income, leading to a mixed investment picture. The reaffirmed full-year guidance provides some reassurance, but investors should monitor profitability closely. The company's strong cash position and stable dividend remain positive factors.
Performance & Financial Health Analysis: Groupe Gorge vs Neurones S.A
| Metric | GOE | NRO |
|---|---|---|
| Market Information | ||
| Market Cap | €1.14B | €977.94M |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 10,268 | 7,407 |
| 90 Day Avg. Volume | 11,807 | 7,621 |
| Last Close | €98.80 | €39.70 |
| 52 Week Range | €16.10 - €128.00 | €39.40 - €52.00 |
| % from 52W High | -22.81% | -23.65% |
| All-Time High | €128.00 (Aug 06, 2025) | €52.00 (Mar 03, 2025) |
| % from All-Time High | -22.81% | -23.65% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.05% |
| Quarterly Earnings Growth | N/A | -0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.58% | 0.06% |
| Operating Margin (TTM) | 0.08% | 0.08% |
| Return on Equity (TTM) | 0.98% | 0.12% |
| Debt to Equity (MRQ) | 3.21 | 0.10 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | €15.58 |
| Cash per Share (MRQ) | N/A | N/A |
| Operating Cash Flow (TTM) | €21.18M | €58.22M |
| Levered Free Cash Flow (TTM) | €46.21M | €52.56M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.76% |
| Last 12-Month Dividend | N/A | €1.30 |
Valuation & Enterprise Metrics Analysis: Groupe Gorge vs Neurones S.A
| Metric | GOE | NRO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 37.96 | 19.13 |
| Forward P/E | 26.16 | 18.09 |
| PEG Ratio | -0.05 | 18.09 |
| Price to Sales (TTM) | 6.38 | 1.17 |
| Price to Book (MRQ) | N/A | 2.56 |
| Market Capitalization | ||
| Market Capitalization | €1.14B | €977.94M |
| Enterprise Value | €1.24B | €693.46M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.94 | 0.86 |
| Enterprise to EBITDA | 47.24 | 6.46 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.53 |
| Book Value per Share (MRQ) | N/A | €15.58 |
Financial Statements Comparison: Groupe Gorge vs Neurones S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GOE | NRO |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GOE | NRO |
|---|---|---|
| Cash & Equivalents | N/A | €326.49M |
| Total Current Assets | N/A | €588.11M |
| Total Current Liabilities | N/A | €252.66M |
| Long-Term Debt | N/A | €29.49M |
| Total Shareholders Equity | N/A | €436.17M |
| Retained Earnings | N/A | €52.56M |
| Property, Plant & Equipment | N/A | €68.09M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GOE | NRO |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GOE | NRO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,268 | 7,407 |
| Average Daily Volume (90 Day) | 11,807 | 7,621 |
| Shares Outstanding | 17.10M | 24.27M |
| Float Shares | N/A | 12.06M |
| % Held by Insiders | N/A | 0.70% |
| % Held by Institutions | N/A | 0.14% |
Dividend Analysis & Yield Comparison: Groupe Gorge vs Neurones S.A
| Metric | GOE | NRO |
|---|---|---|
| Last 12-Month Dividend | N/A | €1.30 |
| Last 12-Month Dividend Yield | N/A | 2.76% |
| 3-Year Avg Annual Dividend | N/A | €1.20 |
| 3-Year Avg Dividend Yield | N/A | 2.76% |
| 3-Year Total Dividends | N/A | €3.60 |
| Ex-Dividend Date | N/A | Jun 11, 2025 |